These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

108 related articles for article (PubMed ID: 26454214)

  • 21. NFkappaB activation and drug sensitivity in human neoplastic cells treated with anthracyclines.
    Gruber BM; Anuszewska EL; Bubko I; Kasprzycka-Guttman T; Misiewicz I; Skupińska K; Fokt I; Piebe W
    Acta Pol Pharm; 2008; 65(2):267-71. PubMed ID: 18666436
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Experimental studies of new anthracyclines: aclacinomycin, THP-adriamycin and ditrisarubicins.
    Umezawa K; Kunimoto S; Takeuchi T
    Biomed Pharmacother; 1987; 41(5):206-13. PubMed ID: 2444279
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Anthracyclines.
    Sinha BK; Politi PM
    Cancer Chemother Biol Response Modif; 1990; 11():45-57. PubMed ID: 2223402
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Pan-histone deacetylase inhibitor panobinostat sensitizes gastric cancer cells to anthracyclines via induction of CITED2.
    Regel I; Merkl L; Friedrich T; Burgermeister E; Zimmermann W; Einwächter H; Herrmann K; Langer R; Röcken C; Hofheinz R; Schmid R; Ebert MP
    Gastroenterology; 2012 Jul; 143(1):99-109.e10. PubMed ID: 22465428
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Iron chelation by clinically relevant anthracyclines: alteration in expression of iron-regulated genes and atypical changes in intracellular iron distribution and trafficking.
    Xu X; Sutak R; Richardson DR
    Mol Pharmacol; 2008 Mar; 73(3):833-44. PubMed ID: 18029550
    [TBL] [Abstract][Full Text] [Related]  

  • 26. HER2-targeted liposomal doxorubicin displays enhanced anti-tumorigenic effects without associated cardiotoxicity.
    Reynolds JG; Geretti E; Hendriks BS; Lee H; Leonard SC; Klinz SG; Noble CO; Lücker PB; Zandstra PW; Drummond DC; Olivier KJ; Nielsen UB; Niyikiza C; Agresta SV; Wickham TJ
    Toxicol Appl Pharmacol; 2012 Jul; 262(1):1-10. PubMed ID: 22676972
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Autophagy inhibition augments the anticancer effects of epirubicin treatment in anthracycline-sensitive and -resistant triple-negative breast cancer.
    Chittaranjan S; Bortnik S; Dragowska WH; Xu J; Abeysundara N; Leung A; Go NE; DeVorkin L; Weppler SA; Gelmon K; Yapp DT; Bally MB; Gorski SM
    Clin Cancer Res; 2014 Jun; 20(12):3159-73. PubMed ID: 24721646
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Predictive value of apoptosis, proliferation, HER-2, and topoisomerase IIalpha for anthracycline chemotherapy in locally advanced breast cancer.
    Arpino G; Ciocca DR; Weiss H; Allred DC; Daguerre P; Vargas-Roig L; Leuzzi M; Gago F; Elledge R; Mohsin SK
    Breast Cancer Res Treat; 2005 Jul; 92(1):69-75. PubMed ID: 15980993
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Pivotal role of innate and adaptive immunity in anthracycline chemotherapy of established tumors.
    Mattarollo SR; Loi S; Duret H; Ma Y; Zitvogel L; Smyth MJ
    Cancer Res; 2011 Jul; 71(14):4809-20. PubMed ID: 21646474
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Anthracyclines in the treatment of gynecologic malignancies.
    Maluf FC; Spriggs D
    Gynecol Oncol; 2002 Apr; 85(1):18-31. PubMed ID: 11925115
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Effects of anthracyclines on reproductive function in rats.
    Borovskaya TG; Gol'dberg ED
    Bull Exp Biol Med; 2000 Nov; 130(11):1066-8. PubMed ID: 11182817
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Effect of structural modifications of anthracyclines on the ability to overcome drug resistance of cancer cells.
    Wasowska M; Wietrzyk J; Opolski A; Oszczapowicz J; Oszczapowicz I
    Anticancer Res; 2006; 26(3A):2009-12. PubMed ID: 16827137
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Injectable Liquid Crystal Formation System for Reshaping Tumor Immunosuppressive Microenvironment to Boost Antitumor Immunity: Postoperative Chemoimmunotherapy.
    Hu M; Zhang J; Yu Y; Tu K; Yang T; Wang Y; Hu Q; Kong L; Zhang Z
    Small; 2020 Dec; 16(50):e2004905. PubMed ID: 33206460
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Enhancement of Fas-mediated apoptosis in renal cell carcinoma cells by adriamycin.
    Wu XX; Mizutani Y; Kakehi Y; Yoshida O; Ogawa O
    Cancer Res; 2000 Jun; 60(11):2912-8. PubMed ID: 10850437
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Poly (ethylene glycol) prodrug for anthracyclines via N-Mannich base linker: design, synthesis and biological evaluation.
    Zhao YJ; Wei W; Su ZG; Ma GH
    Int J Pharm; 2009 Sep; 379(1):90-9. PubMed ID: 19540322
    [TBL] [Abstract][Full Text] [Related]  

  • 36. [A comparative study on in vitro chemosensitivity of urotherial cancers to three anthracyclines].
    Yamada S; Deguchi T; Nezasa S; Kawamoto S; Ehara H; Takahashi Y; Okano M; Fujimoto Y; Isogai K; Kawada Y
    Gan To Kagaku Ryoho; 1996 Sep; 23(10):1339-41. PubMed ID: 8831750
    [No Abstract]   [Full Text] [Related]  

  • 37. Delineation of apoptotic genes for synergistic apoptosis of lexatumumab and anthracyclines in human renal cell carcinoma cells by polymerase chain reaction array.
    Jin X; Wu XX; Jin C; Inui M; Sugimoto M; Kakehi Y
    Anticancer Drugs; 2012 Apr; 23(4):445-54. PubMed ID: 22205156
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Artesunate induces ROS-mediated apoptosis in doxorubicin-resistant T leukemia cells.
    Efferth T; Giaisi M; Merling A; Krammer PH; Li-Weber M
    PLoS One; 2007 Aug; 2(8):e693. PubMed ID: 17668070
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Evaluation of apoptosis induced in vitro by cladribine (2-CdA) combined with anthracyclines in lymphocytes from patients with B-cell chronic lymphocytic leukemia.
    Szmigielska-Kaplon A; Smolewski P; Najder M; Robak T
    Ann Hematol; 2002 Sep; 81(9):508-13. PubMed ID: 12373351
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Effect of therapeutic concentrations of anthracyclines on monocyte phagocytosis of yeast cells.
    Athlin L; Domellöf L; Norberg B
    Eur J Clin Pharmacol; 1989; 36(2):155-9. PubMed ID: 2656271
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.